← Every company
Nektar Therapeutics SEC Filings
What Nektar Therapeutics has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
NKTR overview →Filings on file
143
since Sep 27, 2016
Warning signs
4
latest Apr 4, 2025
Last results
Aug 13, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Nektar Therapeutics's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on NKTR
Company overviewEverything on NKTR in one place, with the price.Insider tradingWhat NKTR's own officers and directors buy and sell.Executive payWhat NKTR awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in NKTR.Funds holding itWhich funds and ETFs hold NKTR, and how big a bet.PatentsWhat NKTR is filing at the patent office.